It’s not easy to get depression-detecting AI through the FDA

California-based startup Kintsugi has ceased operations after failing to obtain FDA clearance for its AI technology aimed at detecting depression and anxiety through speech analysis. The company will release most of its technology as open-source, with potential applications beyond healthcare, including deepfake audio detection. Current mental health assessments remain reliant on traditional patient questionnaires and clinical interviews.

This briefing snippet has been strictly truncated for global aggregation. Operators must securely establish a dedicated intelligence uplink below to access the full operational report exactly as authored by the origin network.